Andrew Galler
Stock Analyst at Morgan Stanley
(0.69)
# 3,050
Out of 4,497 analysts
24
Total ratings
29.41%
Success rate
-16.41%
Average return
Main Sectors:
Top Industries:
8 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| FOLD Amicus Therapeutics | Maintains: Equal-Weight | $14 → $15 | $10.38 | +44.51% | 5 | Nov 9, 2023 | |
| IMCR Immunocore Holdings | Reiterates: Overweight | $79 | $39.78 | +98.59% | 10 | Aug 1, 2023 | |
| SLN Silence Therapeutics | Initiates: Equal-Weight | $18 | $20.67 | -12.92% | 1 | Dec 9, 2022 | |
| ARWR Arrowhead Pharmaceuticals | Maintains: Equal-Weight | $41 → $37 | $28.30 | +30.74% | 2 | Nov 29, 2022 | |
| IONS Ionis Pharmaceuticals | Maintains: Overweight | $57 → $56 | $47.82 | +17.11% | 2 | Nov 10, 2022 | |
| VIR Vir Biotechnology | Maintains: Underweight | $15 → $18 | $10.03 | +79.46% | 2 | Nov 4, 2022 | |
| PTCT PTC Therapeutics | Initiates: Equal-Weight | $54 | $32.63 | +65.49% | 1 | Sep 9, 2022 | |
| HALO Halozyme Therapeutics | Initiates: Overweight | $50 | $54.04 | -7.48% | 1 | Sep 9, 2022 |
Amicus Therapeutics
Nov 9, 2023
Maintains: Equal-Weight
Price Target: $14 → $15
Current: $10.38
Upside: +44.51%
Immunocore Holdings
Aug 1, 2023
Reiterates: Overweight
Price Target: $79
Current: $39.78
Upside: +98.59%
Silence Therapeutics
Dec 9, 2022
Initiates: Equal-Weight
Price Target: $18
Current: $20.67
Upside: -12.92%
Arrowhead Pharmaceuticals
Nov 29, 2022
Maintains: Equal-Weight
Price Target: $41 → $37
Current: $28.30
Upside: +30.74%
Ionis Pharmaceuticals
Nov 10, 2022
Maintains: Overweight
Price Target: $57 → $56
Current: $47.82
Upside: +17.11%
Vir Biotechnology
Nov 4, 2022
Maintains: Underweight
Price Target: $15 → $18
Current: $10.03
Upside: +79.46%
PTC Therapeutics
Sep 9, 2022
Initiates: Equal-Weight
Price Target: $54
Current: $32.63
Upside: +65.49%
Halozyme Therapeutics
Sep 9, 2022
Initiates: Overweight
Price Target: $50
Current: $54.04
Upside: -7.48%